Location: Palo Alto, CA
CIK: 0001892134 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 15, 2024
Total Value: $2.37B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 12,226,943 | $289M | 12.2% | $10.46 | +94.0% | ORDINARY SHARES | N62509109 |
| KRYS | KRYSTAL BIOTECH INC | 988,460 | $176M | 7.4% | $64.17 | +116.5% | COM | 501147102 |
| MIRM | MIRUM PHARMACEUTICALS INC | 6,495,392 | $163M | 6.9% | $23.31 | +18.0% | COM | 604749101 |
| — | HILLEVAX INC | 9,781,472 | $163M | 6.9% | $11.23 | — | COM | 43157M102 |
| — | ALPINE IMMUNE SCIENCES INC | 3,131,008 | $124M | 5.2% | $9.44 | — | COM | 02083G100 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 10,109,279 | $107M | 4.5% | $13.68 | -37.9% | COM | 71722W107 |
| BBIO | BRIDGEBIO PHARMA INC | 3,415,604 | $106M | 4.5% | $20.59 | +65.2% | COM | 10806X102 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 2,190,179 | $94.9M | 4.0% | $19.67 | +122.5% | COM | 76243J105 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 8,785,284 | $87.06M | 3.7% | $17.08 | -56.3% | COM | 03969K108 |
| PCVX | VAXCYTE INC | 1,139,405 | $77.83M | 3.3% | $21.85 | +216.9% | COM | 92243G108 |
| TARS | TARSUS PHARMACEUTICALS INC | 1,787,527 | $64.98M | 2.7% | $17.82 | +65.0% | COM | 87650L103 |
| EWTX | EDGEWISE THERAPEUTICS INC | 3,303,567 | $60.26M | 2.5% | $9.22 | +72.5% | COM | 28036F105 |
| ORIC | ORIC PHARMACEUTICALS INC | 4,142,855 | $56.96M | 2.4% | $8.67 | +37.0% | COM | 68622P109 |
| APLS | APELLIS PHARMACEUTICALS INC | 885,165 | $52.03M | 2.2% | $46.01 | +38.5% | COM | 03753U106 |
| IRON | DISC MEDICINE INC | 785,000 | $48.87M | 2.1% | $38.09 | +70.2% | COM | 254604101 |
| — | VERONA PHARMA PLC | 3,014,349 | $48.5M | 2.0% | $14.56 | — | SPONSORED ADS | 925050106 |
| KALV | KALVISTA PHARMACEUTICALS INC | 3,687,867 | $43.74M | 1.8% | $9.73 | +37.0% | COM | 483497103 |
| RCKT | ROCKET PHARMACEUTICALS INC | 1,561,230 | $42.06M | 1.8% | $18.73 | +51.7% | COM | 77313F106 |
| SLNO | SOLENO THERAPEUTICS INC | 875,667 | $37.48M | 1.6% | $24.43 | +85.2% | COM | 834203309 |
| MGNX | MACROGENICS INC | 2,471,704 | $36.38M | 1.5% | $6.50 | +132.5% | COM | 556099109 |
| — | AEROVATE THERAPEUTICS INC | 1,204,867 | $35.63M | 1.5% | $17.37 | — | COM | 008064107 |
| CGON | CG ONCOLOGY INC | 770,000 | $33.8M | 1.4% | $40.84 | 0.0% | COM | 156944100 |
| — | MERUS N V | 746,479 | $33.61M | 1.4% | $25.59 | — | COM | N5749R100 |
| RVMD | REVOLUTION MEDICINES INC | 997,455 | $32.15M | 1.4% | $25.35 | +16.9% | COM | 76155X100 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 4,623,324 | $29.5M | 1.2% | $4.59 | — | SPON ADS | 05280R100 |
| GPCR | STRUCTURE THERAPEUTICS INC | 629,194 | $26.97M | 1.1% | $41.80 | — | SPONSORED ADS | 86366E106 |
| TRVI | TREVI THERAPEUTICS INC | 7,381,090 | $25.46M | 1.1% | $2.78 | -19.8% | COM | 89532M101 |
| SLN | SILENCE THERAPEUTICS PLC | 1,148,591 | $24.81M | 1.0% | $19.61 | — | ADS | 82686Q101 |
| — | DECIPHERA PHARMACEUTICALS IN | 1,455,837 | $22.9M | 1.0% | $15.49 | — | COM | 24344T101 |
| PEPG | PEPGEN INC | 1,502,788 | $22.09M | 0.9% | $11.81 | 0.0% | COM | 713317105 |
| ANAB | ANAPTYSBIO INC | 899,700 | $20.26M | 0.9% | $30.26 | -21.8% | COM | 032724106 |
| SVRA | SAVARA INC | 4,000,000 | $19.92M | 0.8% | $3.56 | +35.5% | COM | 805111101 |
| — | CEREVEL THERAPEUTICS HLDNG I | 393,000 | $16.61M | 0.7% | $28.54 | — | COM | 15678U128 |
| AGIO | AGIOS PHARMACEUTICALS INC | 523,166 | $15.3M | 0.6% | $24.67 | +8.6% | COM | 00847X104 |
| — | ADVERUM BIOTECHNOLOGIES INC | 1,069,244 | $15.12M | 0.6% | $14.14 | — | COM | 00773U108 |
| PBYI | PUMA BIOTECHNOLOGY INC | 2,816,294 | $14.93M | 0.6% | $5.38 | 0.0% | COM | 74587V107 |
| TYRA | TYRA BIOSCIENCES INC | 832,220 | $13.65M | 0.6% | $11.75 | +39.6% | COM | 90240B106 |
| — | APPLIED THERAPEUTICS INC | 1,952,857 | $13.28M | 0.6% | $6.80 | — | COM | 03828A101 |
| ALLO | ALLOGENE THERAPEUTICS INC | 2,867,750 | $12.82M | 0.5% | $4.17 | 0.0% | COM | 019770106 |
| ARVN | ARVINAS INC | 285,331 | $11.78M | 0.5% | $67.21 | -35.0% | COM | 04335A105 |
| — | 89BIO INC | 1,000,000 | $11.64M | 0.5% | $11.17 | — | COM | 282559103 |
| ACAD | ACADIA PHARMACEUTICALS INC | 470,338 | $8.697M | 0.4% | $17.25 | +43.7% | COM | 004225108 |
| COGT | COGENT BIOSCIENCES INC | 936,576 | $6.294M | 0.3% | $7.30 | -15.4% | COM | 19240Q201 |
| NTLA | INTELLIA THERAPEUTICS INC | 203,684 | $5.603M | 0.2% | $84.72 | -67.2% | COM | 45826J105 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 500,333 | $5.524M | 0.2% | $0.87 | — | *W EXP 11/22/202 | N62509117 |
| ANTX | AN2 THERAPEUTICS INC | 1,388,889 | $4.514M | 0.2% | $11.32 | -3.9% | COM | 037326105 |
| MGX | METAGENOMI INC | 279,025 | $2.944M | 0.1% | $11.50 | 0.0% | COM | 59102M104 |
| — | GRITSTONE BIO INC | 1,030,878 | $2.649M | 0.1% | $4.12 | — | COM | 39868T105 |
| — | BLUEBIRD BIO INC | 1,709,907 | $2.189M | 0.1% | $5.85 | — | COM | 09609G100 |
| ACRS | ACLARIS THERAPEUTICS INC | 264,377 | $328K | 0.0% | $13.64 | -91.3% | COM | 00461U105 |